Company Search:
Advanced Search
Sponsored Links
Biofermin Pharmaceutical Company Limited Company Snapshot
Biofermin Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biofermin Pharmaceutical Company Limited with three other companies in this sector in Japan: Koei Chemical Company, Limited (2019 sales of 18.31 billion Japanese Yen [US$169.54 million] ), Wakamoto Pharmaceutical Co., Ltd. (10.74 billion Japanese Yen [US$99.45 million] ), and I'rom Group Co Ltd (10.58 billion Japanese Yen [US$97.95 million] ).

Sales Analysis. Biofermin Pharmaceutical Company Limited reported sales of ¥11.54 billion (US$106.89 million) for the fiscal year ending March of 2019. This represents an increase of 6.1% versus 2018, when the company's sales were ¥10.88 billion. This was the third consecutive year of growth at Biofermin Pharmaceutical Company Limited. The sales level in 2019 was fairly close to the level five years ago: in 2014, Biofermin Pharmaceutical Company Limited had sales of ¥10.53 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biofermin Pharmaceutical Company Limited
  Stock Performance Chart for Biofermin Pharmaceutical Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (7/19/2019): 2,233.00
(Figures in Japanese Yen)
1 Week -3.0%   13 Weeks 0.2%  
4 Weeks -4.2%   52 Weeks -21.7%  
Biofermin Pharmaceutical Company Limited Key Data:
  Ticker: 4517 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 11,542,869,000
(Year Ending Jan 2020).
Employees: 221
  Currency: Japanese Yen Market Cap: 26,710,266,198
  Fiscal Yr Ends: March Shares Outstanding: 11,961,606
  Share Type: Common Closely Held Shares: 8,030,000
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.